Red cell mass measurement in patients with clinically suspected diagnosis of polycythemia vera or essential thrombocythemia

Haematologica. 2012 Nov;97(11):1704-7. doi: 10.3324/haematol.2012.067348. Epub 2012 Jun 11.

Abstract

The cut off for hemoglobin or hematocrit that indicates the need for an isotopic red cell mass study was investigated in 179 patients with a presumptive diagnosis of polycythemia vera or essential thrombocythemia. Hematocrit showed better diagnostic accuracy than hemoglobin. Hemoglobin over 18.5 g/dL in males or over 16.5 g/dL in females showed a high specificity indicating that red cell mass study could be avoided in such cases, but it showed low sensitivity leading to 46% false negatives. The best value of hematocrit to indicate a red cell mass study was 0.50 L/L in males (specificity 75%, sensitivity 87.5%) and 0.48 L/L in females (specificity 73%, sensitivity 94%). Lowering the hematocrit threshold to 0.48 L/L in males increased sensitivity up to 95%. A red cell mass study should be performed in patients with suspected diagnosis of essential thrombocythemia or polycythemia vera and with hematocrit between 0.48 L/L and 0.52 L/L.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Erythrocyte Volume*
  • Female
  • Hematocrit
  • Hemoglobins / analysis*
  • Hemoglobins / metabolism
  • Humans
  • Male
  • Middle Aged
  • Polycythemia Vera / blood*
  • Polycythemia Vera / diagnosis
  • Retrospective Studies
  • Sex Factors
  • Thrombocytopenia / blood*
  • Thrombocytopenia / diagnosis

Substances

  • Hemoglobins